A. Varan Et Al. , "Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant cisplatin and docetaxel (CD) chemoradiotherapy with plasma EBV DNA quantification," JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15, 2008
Varan, A. Et Al. 2008. Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant cisplatin and docetaxel (CD) chemoradiotherapy with plasma EBV DNA quantification. JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15 .
Varan, A., Ozyar, E., Gultekin, M., Corapcioglu, F., Koksal, Y., AYDIN, G. B. , ... Akyuz, C.(2008). Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant cisplatin and docetaxel (CD) chemoradiotherapy with plasma EBV DNA quantification. JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15.
Varan, A. Et Al. "Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant cisplatin and docetaxel (CD) chemoradiotherapy with plasma EBV DNA quantification," JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15, 2008
Varan, A. Et Al. "Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant cisplatin and docetaxel (CD) chemoradiotherapy with plasma EBV DNA quantification." JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15, 2008
Varan, A. Et Al. (2008) . "Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant cisplatin and docetaxel (CD) chemoradiotherapy with plasma EBV DNA quantification." JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15.
@article{article, author={A. Varan Et Al. }, title={Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma (NPC) patients treated with neoadjuvant cisplatin and docetaxel (CD) chemoradiotherapy with plasma EBV DNA quantification}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2008}